[HTML][HTML] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - BMC cancer, 2020 - Springer
Background Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
[HTML][HTML] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso… - BMC Cancer, 2020 - bmccancer.biomedcentral.com
Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality and
metastatic potential, there is a lack of effective therapies and a low survival rate for this …
metastatic potential, there is a lack of effective therapies and a low survival rate for this …
[PDF][PDF] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - 2020 - ims.ufba.br
Background: Although the pancreatic ductal adenocarcinoma (PDAC) presents high
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
PDAC-ANN: an artificial neural network to predict Pancreatic Ductal Adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - bioRxiv, 2019 - biorxiv.org
Background Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - BMC Cancer, 2020 - go.gale.com
Background Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …
[引用][C] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM Freitas - BMC Cancer (Web), 2020 - jglobal.jst.go.jp
J Clin Invest; Oncogenic Kras is required for both the initiation and maintenance of
pancreatic cancer in mice; MA Collins, F Bednar, Y Zhang, JC Brisset, S Galbán, CJ Galbán; …
pancreatic cancer in mice; MA Collins, F Bednar, Y Zhang, JC Brisset, S Galbán, CJ Galbán; …
[PDF][PDF] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - 2020 - ims.ufba.br
Background: Although the pancreatic ductal adenocarcinoma (PDAC) presents high
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression.
PP Almeida, CP Cardoso, LM de Freitas - BMC Cancer, 2020 - europepmc.org
BACKGROUND: Although the pancreatic ductal adenocarcinoma (PDAC) presents high
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
[PDF][PDF] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - 2020 - d-nb.info
Background: Although the pancreatic ductal adenocarcinoma (PDAC) presents high
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
[PDF][PDF] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
PP Almeida, CP Cardoso, LM de Freitas - 2020 - scholar.archive.org
Background: Although the pancreatic ductal adenocarcinoma (PDAC) presents high
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …
mortality and metastatic potential, there is a lack of effective therapies and a low survival rate …